SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-039365
Filing Date
2014-05-15
Accepted
2014-05-15 16:10:49
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-9552_110q.htm 10-Q 1005072
2 EX-31.1 a14-9552_1ex31d1.htm EX-31.1 11923
3 EX-31.2 a14-9552_1ex31d2.htm EX-31.2 11708
4 EX-32.1 a14-9552_1ex32d1.htm EX-32.1 5231
5 EX-32.2 a14-9552_1ex32d2.htm EX-32.2 5236
  Complete submission text file 0001104659-14-039365.txt   7118954

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20140331.xml EX-101.INS 816597
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20140331.xsd EX-101.SCH 68074
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20140331_cal.xml EX-101.CAL 56130
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20140331_def.xml EX-101.DEF 314350
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20140331_lab.xml EX-101.LAB 1238734
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20140331_pre.xml EX-101.PRE 566343
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE NEW YORK NY 10022 212-831-1111
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 14847292
SIC: 2834 Pharmaceutical Preparations